Nikolcheva T, Pagano G, Anzures-Cabrera J, Trundell D, et al. Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study. Lancet 2026;407:2227-2240.
PMID: 42208564